Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteomyelitis | 4 | 2025 | 8 | 0.420 |
Why?
|
| Vitamin D Deficiency | 2 | 2005 | 24 | 0.270 |
Why?
|
| Kidney Diseases | 3 | 2006 | 121 | 0.260 |
Why?
|
| Humans | 22 | 2025 | 6794 | 0.260 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2018 | 14 | 0.260 |
Why?
|
| Aging | 2 | 2005 | 105 | 0.260 |
Why?
|
| Hypertension | 7 | 2007 | 147 | 0.240 |
Why?
|
| African Americans | 5 | 2008 | 264 | 0.230 |
Why?
|
| Male | 14 | 2025 | 3671 | 0.230 |
Why?
|
| Synovial Fluid | 1 | 2025 | 2 | 0.230 |
Why?
|
| Arthritis, Infectious | 1 | 2025 | 3 | 0.220 |
Why?
|
| Metagenomics | 1 | 2025 | 3 | 0.220 |
Why?
|
| Proteomics | 1 | 2025 | 9 | 0.220 |
Why?
|
| Hypernatremia | 1 | 2005 | 9 | 0.220 |
Why?
|
| Sodium | 1 | 2005 | 43 | 0.220 |
Why?
|
| Hyponatremia | 1 | 2005 | 20 | 0.220 |
Why?
|
| Female | 14 | 2025 | 4060 | 0.220 |
Why?
|
| Dietary Supplements | 1 | 2005 | 44 | 0.210 |
Why?
|
| Acidosis | 1 | 2004 | 30 | 0.210 |
Why?
|
| Adolescent | 10 | 2025 | 869 | 0.210 |
Why?
|
| Child, Preschool | 6 | 2025 | 258 | 0.190 |
Why?
|
| Kidney Failure, Chronic | 4 | 2005 | 420 | 0.190 |
Why?
|
| Child | 7 | 2025 | 524 | 0.190 |
Why?
|
| Nutrition Surveys | 5 | 2008 | 67 | 0.190 |
Why?
|
| Aged | 9 | 2008 | 1539 | 0.180 |
Why?
|
| Cocaine | 1 | 2001 | 22 | 0.170 |
Why?
|
| Middle Aged | 10 | 2008 | 2108 | 0.170 |
Why?
|
| Hospitalization | 1 | 2001 | 128 | 0.160 |
Why?
|
| Substance-Related Disorders | 1 | 2001 | 102 | 0.160 |
Why?
|
| Musculoskeletal Diseases | 1 | 2019 | 4 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 6 | 0.150 |
Why?
|
| Workflow | 1 | 2019 | 7 | 0.150 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 11 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 64 | 0.150 |
Why?
|
| Quality Improvement | 1 | 2019 | 31 | 0.150 |
Why?
|
| United States | 8 | 2008 | 1019 | 0.150 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 118 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 2 | 0.150 |
Why?
|
| Blood Pressure | 3 | 2003 | 112 | 0.130 |
Why?
|
| Adult | 9 | 2008 | 2113 | 0.130 |
Why?
|
| Health Surveys | 3 | 2007 | 75 | 0.130 |
Why?
|
| Cardiovascular Diseases | 3 | 2008 | 172 | 0.130 |
Why?
|
| Risk Factors | 5 | 2007 | 767 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2025 | 331 | 0.120 |
Why?
|
| Infant | 4 | 2019 | 187 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 16 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 2 | 2005 | 115 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 120 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2003 | 145 | 0.090 |
Why?
|
| Prevalence | 5 | 2018 | 259 | 0.090 |
Why?
|
| Age Factors | 4 | 2007 | 193 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2006 | 167 | 0.080 |
Why?
|
| Registries | 2 | 2019 | 63 | 0.080 |
Why?
|
| Comorbidity | 2 | 2018 | 147 | 0.080 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 4 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 197 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 35 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 45 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2019 | 681 | 0.060 |
Why?
|
| Albuminuria | 1 | 2006 | 31 | 0.060 |
Why?
|
| Poverty | 1 | 2006 | 64 | 0.060 |
Why?
|
| Education | 1 | 2005 | 11 | 0.060 |
Why?
|
| Mexican Americans | 1 | 2005 | 14 | 0.060 |
Why?
|
| Benzothiadiazines | 1 | 2005 | 2 | 0.060 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2005 | 2 | 0.060 |
Why?
|
| Vasopressins | 1 | 2005 | 9 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 11 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2025 | 7 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2005 | 15 | 0.060 |
Why?
|
| Diuretics | 1 | 2005 | 13 | 0.060 |
Why?
|
| Arthritis, Juvenile | 1 | 2025 | 9 | 0.060 |
Why?
|
| Acute Disease | 2 | 2015 | 91 | 0.050 |
Why?
|
| California | 2 | 2005 | 230 | 0.050 |
Why?
|
| Acid-Base Equilibrium | 1 | 2004 | 4 | 0.050 |
Why?
|
| Homeostasis | 1 | 2004 | 40 | 0.050 |
Why?
|
| Prognosis | 1 | 2005 | 220 | 0.050 |
Why?
|
| Obesity | 2 | 2007 | 226 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 8 | 0.050 |
Why?
|
| Heart Rate | 1 | 2003 | 29 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2004 | 48 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 58 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 184 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2006 | 497 | 0.040 |
Why?
|
| Age Distribution | 1 | 2001 | 45 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2001 | 44 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2001 | 30 | 0.040 |
Why?
|
| Sex | 1 | 2001 | 1 | 0.040 |
Why?
|
| Systole | 1 | 2001 | 7 | 0.040 |
Why?
|
| Urban Population | 1 | 2001 | 85 | 0.040 |
Why?
|
| Incidence | 1 | 2001 | 197 | 0.040 |
Why?
|
| Texas | 1 | 2019 | 9 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2019 | 13 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2005 | 293 | 0.040 |
Why?
|
| Contrast Media | 1 | 2019 | 18 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 6 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 321 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 108 | 0.040 |
Why?
|
| Young Adult | 1 | 2019 | 567 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2008 | 54 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 2 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2015 | 3 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 5 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 13 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 26 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 18 | 0.030 |
Why?
|
| Phylogeny | 1 | 2015 | 20 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 23 | 0.030 |
Why?
|
| STAT4 Transcription Factor | 1 | 2014 | 1 | 0.030 |
Why?
|
| Resistin | 1 | 2014 | 1 | 0.030 |
Why?
|
| Receptors, Purinergic P2X1 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 3 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 3 | 0.030 |
Why?
|
| Neutrophils | 1 | 2014 | 14 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2014 | 20 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 36 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 31 | 0.030 |
Why?
|
| Sex Factors | 2 | 2007 | 155 | 0.030 |
Why?
|
| Algorithms | 2 | 2004 | 83 | 0.030 |
Why?
|
| Diabetes Mellitus | 2 | 2007 | 208 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 43 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 58 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2007 | 50 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 56 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 104 | 0.020 |
Why?
|
| Indians, North American | 1 | 2005 | 5 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 38 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 63 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 16 | 0.010 |
Why?
|
| Motivation | 1 | 2004 | 42 | 0.010 |
Why?
|
| Life Style | 1 | 2004 | 51 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 56 | 0.010 |
Why?
|
| Body Weight | 1 | 2003 | 90 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 84 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2004 | 56 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 9 | 0.010 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2002 | 2 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 79 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2002 | 41 | 0.010 |
Why?
|
| Pulse | 1 | 2001 | 1 | 0.010 |
Why?
|